Appl Clin Inform 2022; 13(05): 1141-1150
DOI: 10.1055/a-1975-4277
Research Article

Usability and Utility of Human Immunodeficiency Virus Pre-exposure Prophylaxis Clinical Decision Support to Increase Knowledge and Pre-exposure Prophylaxis Initiations among Pediatric Providers

Carrie T. Chan
1   Lucile Packard Children's Hospital, Palo Alto, California, United States
2   Department of Family Health Care Nursing, University of California San Francisco, San Francisco, California, United States
3   Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States
,
Jennifer Carlson
4   Department of Pediatrics—Adolescent Medicine, Stanford University School of Medicine, Palo Alto, California United States
,
Tzielan Lee
5   Department of Pediatrics—Rheumatology, Stanford University School of Medicine, Palo Alto, California, United States
,
Megen Vo
4   Department of Pediatrics—Adolescent Medicine, Stanford University School of Medicine, Palo Alto, California United States
,
Annette Nasr
1   Lucile Packard Children's Hospital, Palo Alto, California, United States
2   Department of Family Health Care Nursing, University of California San Francisco, San Francisco, California, United States
6   Department of Pediatrics-Gastroenterology, Stanford University School of Medicine, Palo Alto, California United States
,
Geoffrey Hart-Cooper
7   Stanford Children's Health, Menlo Park, California, United States
› Author Affiliations
Funding This work was supported by the Stanford Nurse Alumnae Legacy Grant.

Abstract

Objectives An effective clinical decision support system (CDSS) may address the current provider training barrier to offering preexposure prophylaxis (PrEP) to youth at risk for human immunodeficiency virus (HIV) infection. This study evaluated change in provider knowledge and the likelihood to initiate PrEP after exposure to a PrEP CDSS. A secondary objective explored perceived provider utility of the CDSS and suggestions for improving CDSS effectiveness.

Methods This was a prospective study using survey responses from a convenience sample of pediatric providers who launched the interruptive PrEP CDSS when ordering an HIV test. McNemar's test evaluated change in provider PrEP knowledge and likelihood to initiate PrEP. Qualitative responses on CDSS utility and suggested improvements were analyzed using framework analysis and were connected to quantitative analysis elements using the merge approach.

Results Of the 73 invited providers, 43 had available outcome data and were included in the analysis. Prior to using the CDSS, 86% of participants had never been prescribed PrEP. Compared to before CDSS exposure, there were significant increases in the proportion of providers who were knowledgeable about PrEP (p = 0.0001), likely to prescribe PrEP (p < 0.0001) and likely to refer their patient for PrEP (p < 0.0001). Suggestions for improving the CDSS included alternative “triggers” for the CDSS earlier in visit workflows, having a noninterruptive CDSS, additional provider educational materials, access to patient-facing PrEP materials, and additional CDSS support for adolescent confidentiality and navigating financial implications of PrEP.

Conclusion Our findings suggest that an interruptive PrEP CDSS attached to HIV test orders can be an effective tool to increase knowledge and likelihood to initiate PrEP among pediatric providers. Continual improvement of the PrEP CDSS based on provider feedback is required to optimize usability, effectiveness, and adoption. A highly usable PrEP CDSS may be a powerful tool to close the gap in youth PrEP access and uptake.

Protection of Human and Animal Subjects

The study was performed in compliance with the World Medical Association Declaration of Helsinki on Ethical Principles for Medical Research Involving Human Subjects and was reviewed by the Stanford University Institutional Review Board.


Supplementary Material



Publication History

Received: 22 July 2022

Accepted: 15 October 2022

Accepted Manuscript online:
09 November 2022

Article published online:
08 December 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Centers for Disease Control and Prevention. HIV Surveillance Report, 2020; vol. 33. Published May 2022. Accessed July 9, 2022 at: https://www.cdc.gov/hiv/library/reports/hiv-surveillance.html
  • 2 Preexposure Prophylaxis (PrEP) | HIV Risk and Prevention | HIV/AIDS | CDC. Accessed February 6, 2021 at: https://www.cdc.gov/hiv/risk/prep/index.html
  • 3 Centers for Disease Control and Prevention. Core indicators for monitoring the Ending the HIV Epidemic initiative: National HIV Surveillance System Data Reported through December 2021; and Preexposure Prophylaxis (PrEP) Data Reported through September 2021. HIV Surveillance Data Tables 2022;3 (No. 1). . Published May 2022. Accessed July 9, 2022 at: https://www.cdc.gov/hiv/library/reports/surveillance-data-tables/index.html
  • 4 Huang YLA, Zhu W, Wiener J, Kourtis AP, Hall HI, Hoover KW. Impact of coronavirus disease 2019 (COVID-19) on human immunodeficiency virus (HIV) preexposure prophylaxis prescriptions in the United States—a time-series analysis. Clin Infect Dis 2022; 75 (01) e1020-e1027
  • 5 Henny KD, Duke CC, Geter A. et al. HIV-related training and correlates of knowledge, HIV screening and prescribing of nPEP and PrEP among primary care providers in southeast United States, 2017. AIDS Behav 2019; 23 (11) 2926-2935
  • 6 Liu A, Cohen S, Follansbee S. et al. Early experiences implementing preexposure prophylaxis (PrEP) for HIV prevention in San Francisco. PLoS Med 2014; 11 (03) e1001613
  • 7 Mullins TLK, Idoine CR, Zimet GD, Kahn JA. Primary care physician attitudes and intentions toward the use of HIV preexposure prophylaxis in adolescents in one metropolitan region. J Adolesc Health 2019; 64 (05) 581-588
  • 8 Zhang C, McMahon J, Fiscella K. et al. HIV preexposure prophylaxis implementation cascade among health care professionals in the United States: Implications from a systematic review and meta-analysis. AIDS Patient Care STDS 2019; 33 (12) 507-527
  • 9 Moore E, Kelly SG, Alexander L. et al. Tennessee healthcare provider practices, attitudes, and knowledge around HIV preexposure prophylaxis. J Prim Care Community Health 2020; 11: 2150132720984416
  • 10 Pina P, Taggart T, Sanchez Acosta M, Eweka I, Muñoz-Laboy M, Albritton T. Provider comfort with prescribing HIV preexposure prophylaxis to adolescents. AIDS Patient Care STDS 2021; 35 (10) 411-417
  • 11 Pleuhs B, Quinn KG, Walsh JL, Petroll AE, John SA. Health care provider barriers to HIV preexposure prophylaxis in the United States: a systematic review. AIDS Patient Care STDS 2020; 34 (03) 111-123
  • 12 Mullins TLK, Zimet G, Lally M, Xu J, Thornton S, Kahn JA. HIV care providers' intentions to prescribe and actual prescription of preexposure prophylaxis to at-risk adolescents and adults. AIDS Patient Care STDS 2017; 31 (12) 504-516
  • 13 Blumenthal J, Jain S, Krakower D. et al; CCTG 598 Team. Knowledge is power! Increased provider knowledge scores regarding preexposure prophylaxis (PrEP) are associated with higher rates of PrEP prescription and future intent to prescribe PrEP. AIDS Behav 2015; 19 (05) 802-810
  • 14 Blackstock OJ, Moore BA, Berkenblit GV. et al. A cross-sectional online survey of HIV preexposure prophylaxis adoption among primary care physicians. J Gen Intern Med 2017; 32 (01) 62-70
  • 15 Clement ME, Seidelman J, Wu J. et al. An educational initiative in response to identified PrEP prescribing needs among PCPs in the Southern U.S. AIDS Care 2018; 30 (05) 650-655
  • 16 Tripathi A, Ogbuanu C, Monger M, Gibson JJ, Duffus WA. Preexposure prophylaxis for HIV infection: healthcare providers' knowledge, perception, and willingness to adopt future implementation in the southern US. South Med J 2012; 105 (04) 199-206
  • 17 Bacon O, Gonzalez R, Andrew E. et al. Brief report: informing strategies to build PrEP capacity among San Francisco Bay area clinicians. J Acquir Immune Defic Syndr 2017; 74 (02) 175-179
  • 18 Turner L, Roepke A, Wardell E, Teitelman AM. Do you PrEP? A review of primary care provider knowledge of PrEP and attitudes on prescribing PrEP. J Assoc Nurses AIDS Care 2018; 29 (01) 83-92 DOI: 10.1016/J.JANA.2017.11.002.
  • 19 Sales JM, Cwiak C, Haddad LB. et al. Brief Report: impact of PrEP training for family planning providers on HIV prevention counseling and patient interest in PrEP in Atlanta, Georgia. J Acquir Immune Defic Syndr 2019; 81 (04) 414-418
  • 20 Pinto RM, Witte SS, Filippone P, Choi CJ, Wall M. Interprofessional collaboration and on-the-job training improve access to hiv testing, HIV primary care, and preexposure prophylaxis (PREP). AIDS Educ Prev 2018; 30 (06) 474-489
  • 21 Harris NS, Johnson AS, Huang YA. et al. Vital signs: status of human immunodeficiency virus testing, viral suppression, and HIV preexposure prophylaxis - United States, 2013-2018. MMWR Morb Mortal Wkly Rep 2019; 68 (48) 1117-1123
  • 22 Backman R, Bayliss S, Moore D, Litchfield I. Clinical reminder alert fatigue in healthcare: a systematic literature review protocol using qualitative evidence. Syst Rev 2017; 6 (01) 255
  • 23 Nanji KC, Seger DL, Slight SP. et al. Medication-related clinical decision support alert overrides in inpatients. J Am Med Inform Assoc 2018; 25 (05) 476-481
  • 24 Payne TH, Hines LE, Chan RC. et al. Recommendations to improve the usability of drug-drug interaction clinical decision support alerts. J Am Med Inform Assoc 2015; 22 (06) 1243-1250
  • 25 Horsky J, Phansalkar S, Desai A, Bell D, Middleton B. Design of decision support interventions for medication prescribing. Int J Med Inform 2013; 82 (06) 492-503
  • 26 Becker ML, Baypinar F, Pereboom M. et al. The effect of medication related clinical decision support at the time of physician order entry. Int J Clin Pharm 2021; 43 (01) 137-143
  • 27 May A, Hester A, Quairoli K, Wong JR, Kandiah S. Impact of clinical decision support on azithromycin prescribing in primary care clinics. J Gen Intern Med 2021; 36 (08) 2267-2273
  • 28 Ostropolets A, Zhang L, Hripcsak G. A scoping review of clinical decision support tools that generate new knowledge to support decision making in real time. J Am Med Inform Assoc 2020; 27 (12) 1968-1976
  • 29 Oluoch T, Santas X, Kwaro D. et al. The effect of electronic medical record-based clinical decision support on HIV care in resource-constrained settings: a systematic review. Int J Med Inform 2012; 81 (10) e83-e92
  • 30 Gibbs KD, Shi Y, Sanders N. et al. Evaluation of a sepsis alert in the pediatric acute care setting. Appl Clin Inform 2021; 12 (03) 469-478
  • 31 Friebe MP, LeGrand JR, Shepherd BE, Breeden EA, Nelson SD. Reducing inappropriate outpatient medication prescribing in older adults across electronic health record systems. Appl Clin Inform 2020; 11 (05) 865-872
  • 32 Shahmoradi L, Safdari R, Ahmadi H, Zahmatkeshan M. Clinical decision support systems-based interventions to improve medication outcomes: a systematic literature review on features and effects. Med J Islam Repub Iran 2021; 35: 27
  • 33 Schedlbauer A, Prasad V, Mulvaney C. et al. What evidence supports the use of computerized alerts and prompts to improve clinicians' prescribing behavior?. J Am Med Inform Assoc 2009; 16 (04) 531-538
  • 34 Hansen MJ, Carson PJ, Leedahl DD, Leedahl ND. Failure of a best practice alert to reduce antibiotic prescribing rates for acute sinusitis across an integrated health system in the midwest. J Manag Care Spec Pharm 2018; 24 (02) 154-159
  • 35 Devries J, Rafie S, Polston G. Implementing an overdose education and naloxone distribution program in a health system. J Am Pharm Assoc (Wash DC) 2017; 57 (2S): S154-S160
  • 36 Malte CA, Berger D, Saxon AJ. et al. Electronic medical record alert associated with reduced opioid and benzodiazepine coprescribing in high-risk veteran patients. Med Care 2018; 56 (02) 171-178
  • 37 Strom BL, Schinnar R, Aberra F. et al. Unintended effects of a computerized physician order entry nearly hard-stop alert to prevent a drug interaction: a randomized controlled trial. Arch Intern Med 2010; 170 (17) 1578-1583
  • 38 Jaspers MWM, Smeulers M, Vermeulen H, Peute LW. Effects of clinical decision-support systems on practitioner performance and patient outcomes: a synthesis of high-quality systematic review findings. J Am Med Inform Assoc 2011; 18 (03) 327-334
  • 39 Kwan JL, Lo L, Ferguson J. et al. Computerised clinical decision support systems and absolute improvements in care: meta-analysis of controlled clinical trials. BMJ 2020; 370: m3216
  • 40 van den Berg P, Powell VE, Wilson IB, Klompas M, Mayer K, Krakower DS. Primary care providers' perspectives on using automated HIV risk prediction models to identify potential candidates for preexposure prophylaxis. AIDS Behav 2021; 25 (11) 3651-3657
  • 41 Chan CT, Vo M, Carlson J, Lee T, Chang M, Hart-Cooper G. Pediatric provider utilization of a clinical decision support alert and association with HIV preexposure prophylaxis prescription rates. Appl Clin Inform 2022; 13 (01) 30-36
  • 42 Centers for Disease Control and Prevention (CDC). Recommended Training Effectiveness Questions for Postcourse Evaluations: User Guide. CDC; 2019
  • 43 Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol 2013; 13 (01) 117
  • 44 Moseholm E, Fetters MD. Conceptual models to guide integration during analysis in convergent mixed methods studies. Methodol Innov 2017; 10 (02) DOI: 10.1177/2059799117703118.
  • 45 Dailey A, Gant Z, Johnson S. et al. HIV Surveillance Report 2018 (Updated).; 2018
  • 46 Owens DK, Davidson KW, Krist AH. et al; US Preventive Services Task Force. Screening for HIV infection: US preventive services task force recommendation statement. JAMA 2019; 321 (23) 2326-2336
  • 47 Skolnik AA, Bokhour BG, Gifford AL, Wilson BM, Van Epps P. Roadblocks to PrEP: what medical records reveal about access to HIV preexposure prophylaxis. J Gen Intern Med 2020; 35 (03) 832-838
  • 48 Hsu KKC, Rakhmanina NY, Chadwick EG. et al. Adolescents and young adults: the pediatrician's role in HIV testing and pre- and postexposure HIV prophylaxis. Pediatrics 2022; 149 (01) e2021055207
  • 49 Richardson S, Feldstein D, McGinn T. et al. Live usability testing of two complex clinical decision support tools: observational study. JMIR Human Factors 2019; 6 (02) e12471
  • 50 Blecker S, Pandya R, Stork S. et al. Interruptive versus noninterruptive clinical decision support: usability study. JMIR Human Factors 2019; 6 (02) e12469
  • 51 Patterson ES, DiLoreto GN, Vanam R, Hade E, Hebert C. Enhancing usefulness and usability of a clinical decision support prototype for antibiotic stewardship. Proc Int Symp Hum Factors Ergon Healthc 2020; 9 (01) 61-65
  • 52 Phansalkar S, van der Sijs H, Tucker AD. et al. Drug-drug interactions that should be non-interruptive in order to reduce alert fatigue in electronic health records. J Am Med Inform Assoc 2013; 20 (03) 489-493
  • 53 Salwei ME, Hoonakker P, Carayon P, Wiegmann D, Pulia M, Patterson BW. Usability of a human factors-based clinical decision support in the emergency department: lessons learned for design and implementation. Hum Factors 2022; 187208221078625
  • 54 Bates DW, Kuperman GJ, Wang S. et al. Ten commandments for effective clinical decision support: making the practice of evidence-based medicine a reality. J Am Med Inform Assoc 2003; 10 (06) 523-530